Cervical paragangliomas are rare neoplasms that arise from extraadrenal paraganglia in close association with the cranial nerves and extracranial arterial system of the head and neck, and therefore surgical extirpation can be challenging. A retrospective study was conducted of all patients undergoing surgical excision of a cervical paraganglioma between 2000 and 2015. The demographic characteristics, clinical features, surgical approach, and outcomes were reviewed. A total of 20 cervical paragangliomas were excised in 17 patients. There were 14 female and 3 male patients with a mean age of 56.6 ± 17.0 at the time of operation. Twelve patients had unilateral tumors and 5 patients had bilateral tumors. Familial involvement was confirmed by history or direct genetic analysis in 8 (47%) of the 17 patients. There were no malignant paragangliomas, and only 3 patients had tumors that were determined to be functional. Tumor size ranged from 1.3 to 6.0 cm. Two patients required combined arterial resection as part of complete excision of the tumor. There were no permanent operative cranial nerve injuries, no recurrences, minimal morbidity, and no mortality. In conclusion, optimal management of cervical paragangliomas should include a thorough preoperative evaluation, accurate definition of the surgical anatomy, and exclusion of synchronous paragangliomas. A combined therapeutic approach by a multidisciplinary team including surgeons and interventional radiologists provides safe and effective management of cervical paragangliomas with very low morbidity and excellent outcomes. C arotid body tumors (CBTs) are rare neoplasms that arise near the carotid bifurcation within glomus cells derived from the embryonic neural crest. CBTs comprise approximately 65% of head and neck paragangliomas. Most paragangliomas (75%) are sporadic, but a subset (25%) are associated with hereditary paraganglioma syndrome. Cervical paragangliomas arise from the sympathetic ganglia in the head and neck, and similar tumors may arise from the vagus nerve ganglia (glomus vagale) (1-3). Th e majority of sporadic tumors are asymptomatic and initially found by palpation during physical exam, or more commonly as incidental fi ndings on imaging studies (4, 5) . Symptomatic patients present with pain, dysphagia, or autonomic dysfunction (1, 4, 6) .
Cervical paragangliomas are usually benign and biochemically silent, but functional and malignant tumors can occur in a small subset of patients. Sporadic benign tumors typi-cally present between the ages of 40 and 70 years, whereas malignant tumors present at younger ages (20-40 years) (7) . Hereditary paragangliomas result from mutations in the genes for succinate dehydrogenase (SDHD, SDHA, SDHC, SDHB). Patients with hereditary paraganglioma syndrome often undergo routine surveillance and, therefore, tumors can be detected at an earlier stage. Most cervical paragangliomas are slow growing, but left untreated they will eventually result in a progressive enlarging cervical mass with direct involvement and dysfunction of cranial nerves. Complete surgical removal is the treatment of choice for these tumors whenever technically achievable. Excision of CBTs can be technically challenging owing to their proximity to the cranial nerves and the extracranial arterial system, as well as the associated complex anatomy in the head and neck (Figure 1 ). In 1971, Shamblin introduced a classifi cation system for these tumors based on size and extent of local involvement (8) . Th is study reviews the outcomes of a standardized multidisciplinary approach to the treatment of patients with cervical paraganglioma at our institution, in conjunction with a review of previous publications on this topic.
METHODS
After approval by the institutional review board, all patients undergoing treatment for cervical paraganglioma from 2000 to 2015 were identifi ed using a search for the associated ICD-9 diagnosis and CPT procedure codes. Demographic, biochemical, radiographic, and clinicopathologic information was collected by retrospective chart review; this information included age, gender, family history, functionality of the tumor, genetic studies, surgical details (case duration, blood loss), preoperative angioembolization, postoperative outcomes, and operative complications. Th e Shamblin classifi cation was assigned retrospectively according to data from the operative and pathology reports (8) . Th e results were compiled and analyzed using descriptive statistics.
Surgical management of carotid body tumors: a 15-year single institution experience employing an interdisciplinary approach All patients underwent a complete history and physical evaluation by the primary surgical team. A complete family history was obtained, and (in the current era) where appropriate, formal genetic counseling and direct genetic testing for mutations in the succinate dehydrogenase (SDH) subunit genes was performed. Patients with a preoperative diagnosis of paraganglioma underwent biochemical screening to evaluate for a functional tumor, including measurement of fractionated plasma metanephrines and/or excretion of urine catecholamines and metabolites. Although CBTs are infrequently associated with catecholamine hypersecretion, it is our practice to perform biochemical testing for all patients with this diagnosis. Routine screening identifi es those patients with secretory tumors and allows for preoperative alpha blockade to minimize perioperative complications from episodic catecholamine excess. Patients with functional tumors were begun on phenoxybenzamine 10 mg orally in divided doses 7 to 10 days preoperatively to allow for normalization of blood pressure and volume expansion.
Th e preoperative evaluation, diagnostic imaging tests, and invasive procedures for preoperative preparation were performed with a multidisciplinary team approach by members of the interventional radiology, vascular surgery, and endocrine surgery/ surgical oncology services. Appropriate preoperative imaging was performed to assess the size, extent, and anatomic relationships of the tumor. Th ese studies included cross-sectional imaging with contrast-enhanced computed tomography (CT), magnetic resonance imaging (MRI), and/or angiography. Preoperative angioembolization was performed selectively in patients with a tumor that was large, close to critical vessels, or was believed to benefi t from reduced size/vascular supply prior to resection (Figure 2 ). Th e selection of patients for preoperative transarterial catheter embolization was therefore based on surgical judgment, as well as the experience and expertise of the interventional radiologist.
After appropriate preoperative evaluation and informed consent, patients were taken to the operating room for primary excision under general anesthesia. Th e surgical technique included precise anatomic dissection and vascular control prior to attempted tumor excision. Th e dissection to remove the CBT was carried out along the arterial subadventitial plane to allow for complete local tumor excision, as well as preservation of critical vascular structures. In one patient the internal carotid artery required transection. Postoperative care included close pharmacologic control of systolic blood pressure and postoperative clinical neurologic evaluation.
In patients requiring arterial reconstruction following CBT resection, we prefer an autogenous venous conduit if an end-to-end arterial anastomosis is not feasible. Medical therapy following end-to-end reconstruction or venous interposition grafting is typically antiplatelet therapy with aspirin alone for at least a year, depending on the patient's other comorbidities. In the single patient who required arterial reconstruction with a polytetrafl uoroethylene graft/hybrid stent, we elected to keep the patient on dual antiplatelet therapy indefi nitely given the limited data on such reconstructions.
Patients with a known diagnosis of hereditary paraganglioma should undergo lifelong annual biochemical and clinical screening. Annual biochemical testing for plasma and/or urinary catecholamines should begin at age 10 or 10 years before the earliest age of tumor development in the family. Periodic imaging with CT/MRI or 123 I-metaiodobenzylguanidine is indicated for surveillance in patients with a known SDH mutation and in patients with the development of symptoms or if the fractionated metanephrines and/or catecholamines become elevated. After resection of a CBT, patients should continue to have lifelong biochemical and clinical surveillance. Although no clear consensus has been developed regarding when, how, and how often biochemical studies and imaging should be performed, testing should be individualized to the patient.
RESULTS
Seventeen patients were identifi ed with either single or bilateral cervical paragangliomas, and a total of 20 tumors were excised. Th e female to male ratio was 4.7:1, with ages of 22 to 79 years (mean 56.6 ± 17.0) at the time of operation. Th e follow-up period for the study patients was 1 to 126 months (mean 56 ± 34 months). Twelve patients had unilateral tumors and 5 patients had bilateral tumors. Some patients with bilateral involvement underwent removal of the larger tumor fi rst, b a with a smaller asymptomatic contralateral lesion either followed expectantly or with a planned staged resection depending on individual patient and physician preference. A cervical mass was present preoperatively in 8 (47%) patients. Familial involvement was confi rmed by history or direct genetic analysis in 8 (47%) of the 17 patients. Th ere were no malignant paragangliomas in this series, and only three tumors were determined to be functional by preoperative biochemical testing. Th e excised tumors ranged from 1.3 to 6.0 cm (mean 2.76 ± 1.17 cm) in size. Most of the tumors were Shamblin class I and II, as depicted in Table 1 (4, 5, 9-12).
Two patients had recognized preoperative vocal cord paralysis due to tumor involvement of the vagus nerve. Th ere were no permanent operative nerve injuries. One nonfunctioning preoperative nerve was sacrifi ced at the time of tumor resection. Two patients had postoperative diffi culty swallowing that was transient and resolved by the fi rst clinical follow-up visit. Preoperative angiographic embolization was performed for 10 of 20 (50%) of the excised tumors. Two patients required a combined arterial resection as part of complete excision of the tumor. For one patient, an arterial resection was performed and a primary end-to-end anastomosis was achieved for reconstruction. A second patient had reconstruction with a polytetrafl uoroethylene hybrid vascular graft. No patients had tumor recurrence during the follow-up period, and there was no perioperative mortality.
DISCUSSION
A complete preoperative evaluation should be performed in patients with a known or suspected cervical paraganglioma, including a directed family history and genetic testing when appropriate. Hereditary paraganglioma syndromes occur in approximately 25% of cases, and the SDH enzyme complex gene mutation has been identifi ed as the cause of familial types (13) (14) (15) . Patients with hereditary paraganglioma syndrome have a greater incidence of bilateral tumors and develop tumors at a younger age than those with sporadic tumors. Functional tumors are detected by preoperative biochemical screening, including measurement of plasma metanephrines and urine catecholamines. Patients with functional tumors should be prepared preoperatively with alpha-adrenergic receptor blockade to prevent dangerous blood pressure elevations intraoperatively. Hormonally active cervical paragangliomas are reported to be very infrequent (1%-3%) (16) . Only three patients had functional tumors in our series, and most patients were asymptomatic, presenting with either a painless neck mass or the detection of a cervical tumor on imaging obtained for other reasons. Six patients in the current series had familial involvement based on genetic testing or history.
Early excision of cervical paragangliomas is recommended to prevent the development of larger, more locally advanced tumors (Shamblin class III), which are associated with a higher incidence of operative nerve injury as well as poorer outcomes (17). Published nerve injury rates range from 11% to 50% (1, 4, 5, 18, 19) and increase with higher Shamblin class (1, 7). Operative injuries (transient or permanent) of the vagus nerve, hypoglossal nerve, sympathetic chain, or marginal mandibular branch of the facial nerve have been associated with operative treatment of CBTs (5, 18) , especially in larger tumors with close proximity to critical structures requiring a more complex procedure for removal. All but two patients in our series had Shamblin class I or II tumors, and the incidence of transient or permanent cranial nerve injuries in our series is low. Patients with bilateral tumors should undergo staged resections with surgical removal of one side at a time to obviate the risk of synchronous bilateral cranial nerve injury with attendant signifi cant morbidity. Unfortunately, vascular and especially cranial nerve injuries occur relatively frequently in patients requiring excision of large or bilateral CBTs. Th e barorefl ex failure syndrome can occur after the bilateral excision of CBTs (20) . Preoperative embolization of large, vascular tumors can facilitate surgical treatment. Th is typically includes embolization of the ascending pharyngeal branch of the external carotid, allowing for up to 75% reduction in tumor blood fl ow. Th e optimal timing is generally 1 to 2 days prior to surgical excision (4, 21) . At our institution, embolization is performed by neurointerventional radiologists. Th ey also assess the internal carotid artery if there is potential need for ligation. Prior to embolization, a pretest is performed by means of a soft balloon in the internal carotid artery on that side. Th e patient is assessed for any neurologic changes, and the balloon is defl ated if necessary. If no changes are detected, the blood pressure is dropped to simulate mild hypotension (systolic blood pressure 90-100) and verify that the patient still has no symptoms. If the patient passes the test, then the patient will tolerate internal carotid artery ligation without reconstruction.
Most modern series of CBTs reserve preoperative embolization for Shamblin III tumors. In the present series, all Shamblin III and some of the Shamblin I and II tumors underwent preoperative embolization. More liberal use of preoperative embolization during CBT resection for Shamblin I and II tumors has resulted in decreased operative blood loss in individual surgeon experience within our group. Although there is a risk of stroke or other complications with preoperative angiography and embolization, we did not experience that in our small series. Th at risk, albeit small, has limited preoperative embolization for Shamblin I and II tumors at other institutions.
In addition to perioperative complications of nerve injury and bleeding, excision of CBTs is associated with a risk of perioperative stroke. Table 2 shows complication rates in many historical series. Arterial manipulation results in a very small associated stroke risk, which approaches 0% in many experienced hands but can be as high as 11% in some reports (5) . In our series, one patient had a perioperative stroke (5.9%). Th is patient (patient 1) did not require carotid occlusion during the operation. He was initially neurologically intact postoperatively and was discharged home on postoperative day 1. However, he returned on postoperative day 3 with complaints of weakness and slurred speech. He was found to have an infarct of the ipsilateral brainstem on MRI. He subsequently required physical therapy and rehabilitation for convalescence.
Paragangliomas may be initially detected during ultrasound or Doppler ultrasound of the neck; however CT and MRI are more sensitive for accurate tumor measurement (22) . Th e typical radiologic fi ndings include a hypervascular, hypoechoic tumor with splaying of the carotid bifurcation. 123 I-metaiodobenzylguanidine scintigraphy images paraganglioma tumor tissue based on the selective uptake of precursors for catecholamine synthesis, but is most useful in detecting occult paragangliomas or extraadrenal tumors in unusual anatomic sites and is therefore infrequently utilized (16) .
More widespread and frequent use of sensitive imaging modalities enhances early tumor detection. Th is may explain the decreasing rates of radical carotid artery resection and the declining rate of nerve injury (3). Higher Shamblin class tumors are associated with greater blood loss, longer operative times, higher incidence of nerve injury, and the need for vascular sacrifi ce and reconstruction (14, 23) . Complete operative excision remains the treatment of choice for CBTs when it can be performed safely. Th is requires a surgical team with extensive experience and expertise in the management of these complex tumors. Some patients have been treated with radiation therapy for these tumors; however, the current recommendation is for surgical excision alone, unless signifi cant structural involvement prohibits safe surgical exploration (2, 18). 
